Alpha Paradigm Partners’s Fulgent Genetics FLGT Stock Holding History

Alpha Paradigm Partners’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,163	Closed	-$292K	–	585
2021 Q2	$292K	Buy	+3,163	New	+$253K	0.11%	294

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Alpha Paradigm Partners's FLGT Position: Q3 2021 in Review

Alpha Paradigm Partners sold out of Fulgent Genetics (FLGT) in Q3 2021, closing a stake of 3,163 shares — an estimated $292K sold.

Alpha Paradigm Partners first reported a position in FLGT in Q2 2021 and held it in 1 quarter. The position peaked at $292K in Q2 2021. 268 funds tracked by Wall St. Rank hold FLGT as of Q3 2021.

Alpha Paradigm Partners reported no remaining Fulgent Genetics position as of Q3 2021 after selling out during the quarter.
Alpha Paradigm Partners sold 3,163 Fulgent Genetics shares in Q3 2021, an estimated $292K.
Alpha Paradigm Partners first reported a position in Fulgent Genetics in Q2 2021 and held it in 1 quarter.
Alpha Paradigm Partners's Fulgent Genetics position peaked at $292K in Q2 2021.
268 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2021.

Based on Alpha Paradigm Partners's 13F filing for Q3 2021, filed 15 Nov 2021.